The Parallax View

Home
Archive
About
NewTopDiscussion
A post-mortem and a look at what’s next
The Parallax View
Recapping a year of buyout rumors
The Parallax View
1
An exciting approach to auto-immune conditions published in Science shows the broad potential of future mRNA therapies
The Parallax View
2
Our world in charts
The Parallax View
3
Use these to help make $XBI a better place
The Parallax View
8
1
Hi Subscriber, It’s been a busy past few weeks and we wanted to make sure we sent some goodies out to you as we wrap up a few more pieces on our end…
The Parallax View
1
Drugging the undruggable, not redrugging the druggable
The Parallax View
4
COVID-19 Variant & Flu POCT and the New Normal
The Parallax View
1
8,500 words on $TRIL $ALXO $IMAB $STTK $OSE $GILD
The Parallax View
2
Looking at portfolio changes for RA, Perceptive, Baker, OrbiMed, BVF, EcoR1, Redmile, Opaleye, Ghost Tree
The Parallax View
3
2,700 words
The Parallax View
2
1,500 words
The Parallax View
1
© 2022 Substack Inc
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing